Labiana’s nomination is the result of an analysis of its fundamentals, highlighting the company’s ability to combine growth, profitability, and financial strength

• The nomination comes at a particularly significant moment for the company, which is now approaching a market capitalization of €60 million and a share price close to €7

Madrid, June 1, 2026 – Labiana, the pharmaceutical group specialized in animal and human health and listed on BME Growth, has been nominated in the “Best Sustainable Growth on BME Growth” category at the second edition of the Estrategias de Inversión Listed Companies and Investment Funds Awards. This nomination follows a strong stock market performance, with the company’s share price rising by 63.5% during 2025 and gaining an additional more than 40% so far in 2026.

The Estrategias de Inversión Awards are independent recognitions based exclusively on data published by the companies themselves. They acknowledge the most outstanding organizations for their performance, market positioning, operational consistency, and contribution to the market. Labiana’s nomination is the result of an analysis of its fundamentals, which highlights its ability to combine growth, profitability, and financial strength, as well as its positioning to generate sustainable value for shareholders.

The nomination coincides with a particularly significant moment for the company, which is now approaching a market capitalization of €60 million and a share price close to €7. This performance reflects the market’s confidence in Labiana’s strategy, particularly following the signing of the syndicated loan agreement, which replaced the previous financing arrangement with Miralta and strengthened the company’s financial structure. This was further supported by the recent €5 million capital increase, which was oversubscribed by 50%, demonstrating investors’ confidence in Labiana’s business.

This recognition also comes after the company reported record results in 2025, increasing its net profit twelvefold and reaching revenues of €75.2 million, representing a 13.5% increase compared to the previous year.

Manuel Ramos, Chairman and CEO of Labiana, stated that “this nomination recognizes a period of transformation during which we have demonstrated that it is possible to combine growth, profitability, and financial discipline. Over the past few months, we have strengthened our capital structure, improved our market position, and achieved record results—milestones that reflect the successful execution of our strategy and the confidence our business generates in the market. We will continue working to consolidate this growth and create sustainable value for all our shareholders.”

María Mira, Equity Analyst at Estrategias de Inversión, also highlighted the value of the nomination, stating that “it is the most honest, demanding, and valuable reflection of good corporate management. In this way, it rewards growth that is generated through strategic vision, profitability, and efficiency. Growing may be relatively simple, but doing so in a sustainable manner, with operational consistency and a long-term vision, is what truly creates value.”